CLNN
Companies
NASDAQ
Clene Inc.
Health Care
$4.10
-$1.21 (-22.79%)
Price Chart
Overview
About CLNN
clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. our patented clean-surface nanosuspension™ (csn) technology produces clean-surface nanocrystals at commercially viable rates. by coupling high-purity metallic donor materials with high-purity water, csn unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-molecule drugs and large-molecule biologics.
Market Cap
$47.8M
Volume
304.3K
Avg. Volume
272.1K
P/E Ratio
-0.7365439
Dividend Yield
0.00%
Employees
73.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.50
Low Correlation
Volatility
High (0.90)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CLNN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$47.8M
Volume304.3K
P/E Ratio-0.74
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025